Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 98 clinical trials
Featured trial
Alopecia Areata (patchy hair loss)

Alopecia Areata is an autoimmune disorder that causes patches of hair loss to occur and can lead to significant emotional distress. A research study is now underway in the Miami area to

areata alopecia
  • 106 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Hair Loss Study For Men & Women

Hair Loss Study For Men & Women

  • 14656 views
  • 23 Nov, 2020
  • 1 location
Featured trial
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

  • 2303 views
  • 23 Nov, 2020
  • 1 location
None
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

  • 43 views
  • 27 Jan, 2021
  • 1 location
None
AGA Biocellular Stem/Stromal Hair Regenerative Study

) and high density platelet-rich plasma concentrate (HD- PRP) as compared with adipose-derived cell-enriched SVF (AD-cSVF) + AD-tSVF and HD- PRP concentrates in treatment of androgenetic alopecia (AGA

  • 33 views
  • 28 Jan, 2021
  • 1 location
None
A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central centrifugal cicatricial alopecia (CCCA) is form of scarring hair loss that predominately affects middle-aged women of African descent.1 . Clinically, the natural progression of CCCA

  • 2 views
  • 28 Jul, 2021
  • 1 location
None
Long-Term PF-06651600 for the Treatment of Alopecia Areata

This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia

androgenic alopecia
areata alopecia
alopecia
alopecia totalis
pf-06651600
  • 1661 views
  • 10 Oct, 2021
  • 178 locations
None
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to

areata alopecia
alopecia
  • 493 views
  • 25 Sep, 2021
  • 48 locations
None
To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases

Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 % among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with successful

  • 18 views
  • 21 Sep, 2021
  • 1 location
None
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)

This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair

areata alopecia
  • 47 views
  • 19 Sep, 2021
  • 83 locations